Skip to main content
logo
Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.020
-0.150 (-6.91%)
At close: May 15, 2026, 4:00 PM EDT
2.110
+0.090 (4.46%)
After-hours: May 15, 2026, 7:57 PM EDT

Innate Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
182164149225297363
Market Cap Growth
1.04%9.73%-33.66%-24.22%-18.14%12.22%
Enterprise Value
168.11139.7188.42157.03231.13241.8
Last Close Price
2.021.751.842.803.734.56
PE Ratio
--2.71-2.90-28.11-4.77-6.08
PS Ratio
17.2015.507.133.304.8012.91
PB Ratio
--6.4316.243.925.112.97
P/TBV Ratio
-8.34-7.2216.904.345.493.38
P/FCF Ratio
--2.64-19.69-6.18-14.06-5.37
P/OCF Ratio
--2.65-20.80-6.25-14.45-5.46
EV/Sales Ratio
15.9013.224.222.303.748.61
EV/EBITDA Ratio
--2.26-1.71-18.74-17.93-4.92
EV/EBIT Ratio
--2.20-1.65-11.21-3.75-4.45
EV/FCF Ratio
--2.25-11.66-4.32-10.94-3.58
Debt / Equity Ratio
-0.63-0.632.520.600.740.13
Debt / EBITDA Ratio
-0.43-0.43-0.62-5.26-3.51-1.02
Debt / FCF Ratio
-0.43-0.43-4.25-1.21-2.15-0.74
Net Debt / Equity Ratio
0.540.54-5.63-1.01-1.09-0.70
Net Debt / EBITDA Ratio
0.220.221.006.944.931.75
Net Debt / FCF Ratio
0.220.226.831.603.011.27
Asset Turnover
0.100.100.140.320.240.09
Quick Ratio
1.271.272.603.733.381.73
Current Ratio
1.271.272.603.733.381.73
Return on Equity (ROE)
764.21%764.21%-162.91%-14.28%-71.75%-34.53%
Return on Assets (ROA)
-62.16%-62.16%-36.04%-6.61%-24.16%-16.64%
Return on Invested Capital (ROIC)
-390.67%-390.67%-128.95%-16.76%-56.15%-38.99%
Return on Capital Employed (ROCE)
-103.72%-103.72%-48.28%-8.39%-32.43%-21.28%
Earnings Yield
-31.76%-36.91%-34.46%-3.56%-20.98%-16.46%
FCF Yield
-33.93%-37.89%-5.08%-16.17%-7.11%-18.62%
Buyback Yield / Dilution
-10.54%-10.54%-0.74%-1.02%-0.12%-0.77%
Total Shareholder Return
-10.54%-10.54%-0.74%-1.02%-0.12%-0.77%
Updated Feb 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q